Recombinant DNA Advisory Committee - 06/7-8/93 
John Bishop, Food and Drug Administration 
G'dali Braverman, Act Up 
Louis Bucalo, Ingenex, Inc. 
Barrie Carter, Targeted Genetics, Inc. 
Yawen Chiang, Genetic Therapy, Inc. 
Edward Cohen, University of Illinois 
Barbara Culliton, Nature Magazine 
David Danar, Lehman Brothers 
Timothy Darrow, Duke University 
Tapas DasGupta, University of Illinois 
Wanda de Vlaminck, Avigen, Inc. 
Albert Deisseroth, MD Anderson Cancer Research Center 
Michelle Durand, The French Embassy 
Suzanne Epstein, Food and Drug Administration 
Mason Essif, CNN 
Susan Falen, Genetic Therapy, Inc. 
Therese Falk, The Swedish Embassy 
Ron Feldbaum, Financial Times 
Mitchell Finer, Cell Genesys, Inc. 
Bruce Fink, CNN 
Bemie Fox, University of Michigan 
Jeffrey Fox, BioTechnology 
Ralph Freedman, MD Anderson Cancer Research Center 
Siqing Fu, MD Anderson Cancer Research Center 
Morgan Gale, Hearings-on-the-Line 
J. David Gallagher, Barksdale Ballard 
Jeffrey Galpin, Viagene, Inc. 
Cyril Gay, Department of Agriculture 
Lisa Giglio, The Pink Sheet 
Richard Giles, University of Illinois 
Robert Gilley, CNN 
Steve Goff, Columbia University 
T. Venkat Gopal, Clonexpress, Inc. 
Cheryl Graham, Biometric Research Institute 
Aileen Griffin, Viagene, Inc. 
John Griffin, Viagene, Inc. 
Janet Grun, Advanced Biosearch Associates 
Elie Hanania, MD Anderson Cancer Research Center 
Susanna Hegewisch, MD Anderson Cancer Research Center 
Russell Herndon, Genzyme Corporation 
Patrick Herve, CRTS Besancon, France 
Charles Hesdorffer, Columbia Presbyterian Medical Center 
[546] 
Recombinant DNA Research, Volume 17 
